Immunity, endothelial injury and complement-induced coagulopathy in COVID-19
In December 2019, a novel coronavirus was isolated from the respiratory epithelium of
patients with unexplained pneumonia in Wuhan, China. This pathogen, named severe acute …
patients with unexplained pneumonia in Wuhan, China. This pathogen, named severe acute …
COVID‐19: Virology, biology and novel laboratory diagnosis
Background At the end of December 2019, a novel coronavirus tentatively named SARS‐
CoV‐2 in Wuhan, a central city in China, was announced by the World Health Organization …
CoV‐2 in Wuhan, a central city in China, was announced by the World Health Organization …
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study
CM Petrilli, SA Jones, J Yang, H Rajagopalan… - bmj, 2020 - bmj.com
Objective To describe outcomes of people admitted to hospital with coronavirus disease
2019 (covid-19) in the United States, and the clinical and laboratory characteristics …
2019 (covid-19) in the United States, and the clinical and laboratory characteristics …
COVID-19 and its implications for thrombosis and anticoagulation
JM Connors, JH Levy - Blood, The Journal of the American …, 2020 - ashpublications.org
Severe acute respiratory syndrome coronavirus 2, coronavirus disease 2019 (COVID-19)-
induced infection can be associated with a coagulopathy, findings consistent with infection …
induced infection can be associated with a coagulopathy, findings consistent with infection …
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
Abstract Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the
severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients …
severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients …
COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options
TJ Guzik, SA Mohiddin, A Dimarco, V Patel… - Cardiovascular …, 2020 - academic.oup.com
The novel coronavirus disease (COVID-19) outbreak, caused by SARS-CoV-2, represents
the greatest medical challenge in decades. We provide a comprehensive review of the …
the greatest medical challenge in decades. We provide a comprehensive review of the …
Cardiovascular complications in COVID-19
Background The coronavirus disease of 2019 (COVID-19) is caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). While systemic inflammation and …
respiratory syndrome coronavirus 2 (SARS-CoV-2). While systemic inflammation and …
Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic …
The COVID-19 pandemic is an unprecedented healthcare emergency causing mortality and
illness across the world. Although primarily affecting the lungs, the SARS-CoV-2 virus also …
illness across the world. Although primarily affecting the lungs, the SARS-CoV-2 virus also …
Scientific and standardization committee communication: clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized …
2 METHODS This guidance statement is a collaborative effort of the Perioperative and
Critical Care Thrombosis and Haemostasis Subcommittee, along with members of the …
Critical Care Thrombosis and Haemostasis Subcommittee, along with members of the …
COVID-19 presenting as stroke
Objective Acute stroke remains a medical emergency even during the COVID-19 pandemic.
Most patients with COVID-19 infection present with constitutional and respiratory symptoms; …
Most patients with COVID-19 infection present with constitutional and respiratory symptoms; …